Section 1. Short title
This Act may be cited as the Protecting Resources Of Taxpayers to Eliminate Childhood Transgender Surgeries Act of 2024 or the PROTECTS Act of 2024.
(a) In general
Notwithstanding any other provision of law, no Federal funds may be used or otherwise made available to provide or refer for a specified gender transition procedure to an individual under the age of 18 or to reimburse any entity for providing such a procedure to such an individual.
(1) In general
For purposes of this paragraph, except as provided in paragraph (2), the term specified gender transition procedure means, with respect to an individual, any of the following when performed for the purpose of intentionally changing the body of such individual to no longer correspond to their sex:
(A) Performing any surgery, including—
(i) castration;
(ii) orchiectomy;
(iii) scrotoplasty;
(iv) vasectomy;
(v) hysterectomy;
(vi) oophorectomy;
(vii) ovariectomy;
(viii) metoidioplasty;
(ix) penectomy;
(x) phalloplasty;
(xi) vaginoplasty;
(xii) vaginectomy;
(xiii) vulvoplasty;
(xiv) reduction thyrochondroplasty;
(xv) chondrolaryngoplasty;
(xvi) mastectomy; and
(xvii) any plastic, cosmetic, or aesthetic surgery that feminizes or masculinizes the facial or other body features of an individual.
(B) Any placement of chest implants to create feminine breasts.
(C) Any placement of fat or artificial implants in the gluteal region.
(D) Administering, supplying, prescribing, dispensing, distributing, or otherwise conveying to an individual medications, including—
(i) gonadotropin-releasing hormone (GnRH) analogues or other puberty-blocking drugs to stop or delay normal puberty; and
(ii) testosterone, estrogen, or other androgens to an individual at doses that are supraphysiologic than would normally be produced endogenously in a healthy individual of the same age and sex.
(2) Exception
Paragraph (1) shall not apply to the following when furnished to an individual by a health care provider with the consent of such individual’s parent or legal guardian:
(A) Puberty suppression or blocking prescription drugs for the purpose of normalizing puberty for an individual experiencing precocious puberty.
(B) Appropriate and medically necessary procedures or treatments to correct for—
(i) a medically verifiable genetic disorder of sex development, including—
(I) 46,XX chromosomes with virilization;
(II) 46,XY chromosomes with undervirilization; and
(III) both ovarian and testicular tissue;
(ii) sex chromosome structure, sex steroid hormone production, or sex hormone action, if determined to be abnormal by a physician through genetic or biochemical testing; or
(iii) infection, disease, injury, or disorder caused or exacerbated by a previous procedure described in paragraph (1), or a physical disorder, physical injury, or physical illness that would, as certified by a physician, place the individual in imminent danger of death or impairment of a major bodily function unless the procedure is performed, not including procedures performed for the alleviation of mental distress.
(3) Sex
For purposes of paragraph (1), the term sex means the indication of male or female sex by reproductive potential or capacity, sex chromosomes, naturally occurring sex hormones, gonads, or internal or external genitalia present at birth.